Drugs / Gualou Xiebai Banxia Decoction
Gualou Xiebai Banxia Decoction
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03171597 | Aug 2017 → Oct 2019 | intermediate coronary syndrome | Jun Li | Unknown | No outcome recorded |
| Phase 4 | NCT03179514 | Jul 2017 → Oct 2019 | intermediate coronary syndrome | Jun Li | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gualou Xiebai Banxia Decoction | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03171597 ↗ |
| Known as | GLXBBX | “We systematically assess the current clinical evidence of Gualouxiebaibanxia (GLXBBX) decoction for the treatment of angina pectoris (AP).” PMID 27777598 ↗ Sep 2016 |
| Known as | Gualouxiebaibanxia | “We systematically assess the current clinical evidence of Gualouxiebaibanxia (GLXBBX) decoction for the treatment of angina pectoris (AP).” PMID 27777598 ↗ Sep 2016 |
| Modality | Traditional medicine (herbal / TCM) | “The Effect of Chinese Herbal Medicine Gualouxiebaibanxia Decoction for the Treatment of Angina Pectoris: A Systematic Review.” PMID 27777598 ↗ Sep 2016 |